Authored by: Liu Cheng , Audrey Li , Yelena Wang and Jiang Hanxue

On June 24, 2024, the Supreme People’s Court of the People’s Republic of China (“SPC”) issued the Interpretation of Several Issues Concerning the Application of Law in the Trial of Private Litigations over Monopolistic Conducts (the “Judicial Interpretation”), which took effect since July 1, 2024.

Chinese antitrust cases have grown more common and complicated in recent years. The people’s courts in China have released 656 rulings in private antitrust cases since the PRC Anti-monopoly Law (“AML”) went into force in 2008, including first instance cases and appeals. Numerous industries have been affected by the lawsuits, including the Internet, public utilities, pharmaceutical, petrochemical, and automotive sectors. Some of the cases have also had a broad social impact.

Read More

Authored by: Zhang Suqiang and Huang Ling

During corporate restructuring and certain cross-border equity transactions, such as the set-up or dismantling of “red-chip” structure, a frequently encountered tax issue is whether non-resident enterprises are entitled to “special tax treatment” for cross-border equity transfers so that a tax deferral applies. Thus, the interpretation and application of the “specific conditions” as stipulated by tax law comes to be an unavoidable issue. With the implementation of the tax administration reform of “delegating power, improving regulation, and providing services”, “special tax treatment” no longer requires prior approval by tax authorities; instead, taxpayers are required to make self-assessments, and subsequently make self-reports or filings, and the tax authorities supervise through post-transaction administration. This requires a much better understanding and implementation by enterprises of tax policies, and brings greater challenges, even exposes them to the risk of overdue taxes and late payment interests, thus causing significant “concerns” for corporate restructuring. This article, based on our practical observations, provides insights on how to evaluate the controversial issue of “changes in future withholding tax burdens” to determine the applicability of “special tax treatment” for non-resident enterprise restructuring.

Read More

作者:张素强 黄玲

在企业重组及搭红筹、拆红筹等跨境股权交易过程中,经常遇到的税务问题是非居民企业跨境股权转让能否适用特殊性税务处理以实现递延纳税,此时,对“税法规定的特定条件”的理解与适用就成为无法回避的问题。随着税务征管“放、管、服”的落地,特殊性税务处理不再执行事前审批,而是要求纳税人自行判断、事后申报或备案,税务机关通过后续管理的方式进行监管。这对企业正确理解和执行税收政策提出了更高的要求、带来了更大的挑战,甚至面临事后被追缴税款、滞纳金的风险,为企业重组带来严重的“后顾之忧”。本文根据我们的实务观察,就非居民企业股权重组特殊性税务处理适用条件中的“造成以后预提税负担变化”应如何判断与权衡这一实践中的争议难题,提供一些“破题”的思路,以供探讨。

阅读更多

作者:章慈 王晨璐

我们在上篇文章《企业出海税务指南系列文章(一):海外控股架构搭建税务考量》中介绍了海外控股架构搭建过程中的税务考量因素,即选择直接持股还是间接持股,搭建几层海外架构以及在何处设立中间控股公司。在本篇文章中,我们将着重阐述知识产权持有平台搭建、利润派回方式选择以及构建集团关联交易等海外业务规划中的税务考量。

阅读更多

作者:戴梦皓 郑子懿 傅嫣儒

2024年10月28日,美国财政部正式发布了基于第14105号总统行政令——《关于解决美国对受关注国家的特定国家安全技术和产品投资的行政令》(“E.O.14105”)的最终规则“关于美国在受关注国家投资有关国家安全技术和产品的规定”(“最终规则”)。相关最终规则将于2025年1月2日生效。自2023年8月9日拜登政府正式发布E.O.14105后,经过一年多紧锣密鼓的准备,美国政府最终完成了对外投资审查的基本立法工作,进入全面实施阶段。从内容上来看,最终规则基本保留了3个多月前美国财政部所发布的拟议规则(“NPRM”)的主要内容,仅进行了部分条款的调整和细化。但是,正如我们在过去一年多时间内所多次提示的那样,新的对外投资审查机制将对半导体、量子计算和人工智能(“AI”)等关键领域的投融资活动带来深远影响,全面改变相关的投资业态。在此,我们结合本次最终规则的调整内容和相关业务场景,以及我们所了解的后续立法动态,就相关外国投资审查机制在未来实施中的注意要点进行展望,希望能对大家有所帮助。

阅读更多

Authored by: Duan Tao(Daisy) , Yang Yingjie and Li Cuishi

Standfirst: The amended PRC Company Law will have many, far-reaching effects, including motivating companies to reduce their registered capital in order to optimize capital utilization. This article introduces the motivations and tax implications associated with one possible route: formal capital reductions.

Read More

作者:宁宣凤 吴涵 方禹 吴真恺 苏琦

在保险业数据合规前期系列解读中,我们分别详细介绍了保险业数据合规的典型案例、整体的法律体系以及保险业实践中的主要合规场景及要点。而对保险企业而言,构建一个健全的内部网络安全与数据合规体系对于保护客户信息、维护企业声誉以及遵守法律法规至关重要。一方面,保险行业涉及大量敏感个人信息,这些数据一旦泄露,不仅会导致客户信任度下降,还可能引发法律诉讼以及高额罚款。另一方面,随着网络攻击的增加,保险企业必须确保其系统能够抵御外部威胁,如黑客攻击和数据泄露。因此,本文在前期合规要点梳理的基础上,将进一步系统性地梳理保险公司将如何构建适合自身的网络安全与数据合规制度框架,以助力保险公司在内部管理实践中高效开展具体工作。

阅读更多

作者:姜志会 葛杰 Tom Harrison 刘峻成

2024年11月1日,商务部、中国证监会、国务院国资委、税务总局、市场监管总局、国家外汇局联合发布修订后的《外国投资者对上市公司战略投资管理办法》(以下简称“《战投新规》”),自2024年12月2日起施行。为保障《战投新规》的顺利实施,六部门有关司局负责人就有关问题举行了答记者问。

本文尝试对上述新规的历史演变、适用范围、适用方式等方面进行初步分析总结,以供拟战略投资A股上市公司的外国投资者参考。

阅读更多

作者:宁宣凤 吴涵 方禹

10月30日,北京互联网法院召开涉个人信息及数据相关案件审理情况新闻通报会,发布了八起典型案例,强调在保护个人信息权益的前提下,通过规范个人信息处理活动,促进数据在生产、流通、使用过程中的合理利用,推动数字经济高质量发展。值得注意的是,这次发布恰逢《个人信息保护法》实施三周年,八起典型案例覆盖了告知同意、数据权益、公开个人信息处理、用户义务等个人信息保护重点环节,对个人信息保护合规具有清晰、直接的参考意义。

金杜网络安全与数据合规团队对八起典型案例进行了梳理、概括,为相关企业个人信息保护合规提供参考。

阅读更多

Authored by: Sun Xing , Zhang Wenyi , Zheng Bowen and Zhi Yuan

In July 2024, the Guangdong Provincial Medical Products Administration (hereinafter referred to as “GDMPA”) reported a significant case of smuggling involving unapproved drugs, which has raised substantial attention from the public. This case, notable for its high level of organization and considerable financial implications, is uncommon in recent years. Authorities successfully seized over 5,000 boxes containing more than 80 different types of smuggled drugs, with the total estimated value reaching RMB 200 million. All drugs involved were unapproved for sale within China’s borders and primarily included drugs intended for the prevention and treatment of cancer, as well as the treatment of diabetes and other serious illness.

Read More